$PEPG

PepGen Inc. (PEPG): Submission of Matters to a Vote of Security Holders

PepGen Inc. (PEPG) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. 8-K false 0001835597 0001835597 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18,

Original reporting
Published Jun 22, 2026, 8:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 22, 2026, 8:33 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$PEPG
Neutral
high confidence
Mentioned
$PEPG
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PEPGNeutralLow
01

Why it matters

The disclosure confirms the election of three Class I directors and ratification of KPMG LLP as independent auditor for the fiscal year ending December 31, 2026; it does not provide new operating or financial guidance.

02

Market read

Traders may note governance continuity, but there is no new catalyst for earnings, trials, financing, or M&A in the text.

03

What to watch

The filing does not include vote margins, director performance context, or any new corporate actions beyond standard meeting results.

Relevance 6/10Novelty 2/10Timing: after-hours/filing date (June 22, 2026) following June 18 annual meeting

Background

This is an SEC Form 8-K (Item 5.07) reporting matters submitted to stockholders at PepGen’s June 18, 2026 annual meeting.

Company-level read

Ticker impact

$PEPGNeutralHigh confidence
Context

PepGen disclosed 2026 annual meeting voting results, including director elections and ratification of KPMG as auditor for 2026.

Expected impact

Low likelihood of a sustained price move solely from this 8-K voting disclosure.

Evidence & confidence

The 8-K reports routine outcomes (board election and auditor ratification) without new financial guidance, transactions, or regulatory actions.

Market effects

Minimal; governance/auditor ratification does not change biotech sector risk or competitive dynamics.

Minimal; no broader market or regional policy/regulatory signal is included.

Minimal; no international deal, trial, or regulatory development is disclosed.

Counterpoint

If investors were concerned about governance or auditor continuity, the ratification could reduce uncertainty, but the effect is usually small.

Key entities

  • PepGen Inc.

    Subject of the 8-K; reported annual meeting voting outcomes and auditor ratification.

  • KPMG LLP

    Ratified as PepGen’s independent registered public accounting firm for FY ending Dec. 31, 2026.

Related articles

$PEPGMed

PepGen Inc. (PEPG): Results of Operations and Financial Condition

PepGen Inc. (PEPG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 pepg-ex99_1.htm EX-99.1 EX-99.1 PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights – DSMB recommends advancement of PGN-EDODM1 into the highest dose cohort in the FREEDOM2-DM1 study, as well as FREEDOM-OLE dose escalation from 5 mg/kg t

$SKHYMed

SK Hynix’s $38 billion buildout has a name attached: Nvidia

SK Hynix (SKHY) approved about 54.3 trillion won (about $38.3B) for two memory plants through 2031, Reuters reported. About 35.2 trillion won funds a DRAM fab in Yongin (Y2) with construction starting July 2027 and first cleanroom June 2029. Remaining 19.1 trillion won supports a NAND plant in Cheongju. Reuters also said it is reviewing further shareholder returns.

$ITWMed

Illinois Tool Works Authorizes $6 Bln Buyback

Illinois Tool Works (ITW) said its board authorized a new share repurchase program of up to $6 billion. The board also approved a 7% increase in its regular annual cash dividend to $6.88 per share, effective with the Q4 dividend of $1.72 payable Oct. 9, 2026. ITW closed at $296.66 on Friday.

$JNJMed

Money talcs: Why J&J offered $5.5bn to end cancer cases

Johnson & Johnson is offering $5.5 billion to settle most of more than 70,000 pending talc-related cancer lawsuits, according to the company. Claims allege ovarian cancer or mesothelioma linked to asbestos-contaminated talc. J&J denies wrongdoing and says cases lack merit. Prior orders include $966m (LA) and $1.5bn (Baltimore), with appeals planned.

$AAPLMed

Trump Tariff Refunds Just Topped $100 Billion, and These Companies Are Receiving Some of the Largest Checks

The U.S. Supreme Court invalidated Trump IEEPA tariffs, leaving the administration to refund about $166 billion. By Aug. 4, refunds exceeded $100 billion. Apple received $2.19 billion, Amazon $600 million, and others including Walmart ($2.4B), Ford ($1.3B), GM ($500M), and Costco (~$2B) are expected to receive large checks. New Section 301 tariffs may affect prices.